|
Resistance patterns of the seven most common bacteria for Hospital-acquired Infections (HAI) and Community-acquired Infections (CAI), China 2001 |
||||||||||||||||
| unit: % |
||||||||||||||||
|
|
||||||||||||||||
| Antibiotic(s) |
SAU (n = 176) |
SEP (n = 84) |
ECO (n = 308) |
ECL (n = 78) |
PAE (n = 232) |
KPN (n = 215) |
ABA (n = 191) |
γ |
||||||||
|
|
||||||||||||||||
| HAI (37) |
CAI (139) |
HAI (14) |
CAI (70) |
HAI (44) |
CAI (264) |
HAI (27) |
CAI (51) |
HAI (95) |
CAI (137) |
HAI (48) |
CAI (167) |
HAI (46) |
CAI (145) |
HAIγH |
CAIγC |
|
|
|
||||||||||||||||
| Methicillin |
89 |
30 |
43 |
27 |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
11 |
5 |
|
|
||||||||||||||||
| Ampicillin |
100 |
82 |
86 |
67 |
89 |
80 |
100 |
90 |
n/a |
n/a |
54 |
66 |
n/a |
n/a |
38 |
35 |
| Amoxicillin |
89 |
27 |
29 |
6 |
84 |
81 |
100 |
94 |
n/a |
n/a |
90 |
95 |
48 |
50 |
38 |
31 |
| Ceftizoxime |
87 |
28 |
14 |
7 |
32 |
25 |
96 |
86 |
n/a |
n/a |
33 |
26 |
96 |
92 |
24 |
16 |
| Cefaclor |
87 |
31 |
21 |
10 |
32 |
26 |
89 |
78 |
n/a |
n/a |
33 |
25 |
65 |
57 |
23 |
15 |
| Cefuroxime |
89 |
29 |
22 |
4 |
32 |
25 |
74 |
47 |
n/a |
n/a |
29 |
23 |
57 |
41 |
22 |
12 |
| Cefprozil. |
87 |
26 |
21 |
4 |
34 |
25 |
78 |
61 |
n/a |
n/a |
33 |
23 |
94 |
86 |
24 |
15 |
| Ceftazidime |
92 |
37 |
50 |
13 |
5 |
7 |
59 |
28 |
11 |
14 |
21 |
4 |
30 |
15 |
19 |
8 |
| Cefotaxime |
84 |
28 |
21 |
6 |
0 |
7 |
44 |
26 |
41 |
26 |
4 |
5 |
28 |
16 |
15 |
8 |
| Ceftriaxone |
89 |
28 |
21 |
3 |
9 |
8 |
48 |
29 |
40 |
25 |
6 |
5 |
33 |
15 |
18 |
8 |
| Imipenem |
76 |
21 |
21 |
1 |
2 |
0 |
0 |
2 |
2 |
3 |
0 |
1 |
2 |
1 |
8 |
2 |
| Meropenem |
78 |
21 |
14 |
1 |
2 |
0 |
0 |
0 |
2 |
2 |
0 |
1 |
2 |
2 |
8 |
2 |
| Ciprofloxacin |
87 |
35 |
36 |
30 |
75 |
53 |
63 |
33 |
26 |
13 |
19 |
14 |
26 |
17 |
29 |
18 |
| Ofloxacin |
78 |
30 |
36 |
30 |
75 |
55 |
59 |
31 |
17 |
15 |
15 |
14 |
22 |
17 |
27 |
18 |
| Levofloxacin |
46 |
7 |
29 |
10 |
68 |
52 |
33 |
20 |
22 |
15 |
10 |
11 |
13 |
12 |
21 |
13 |
| Sparfloxacin |
89 |
39 |
50 |
40 |
75 |
56 |
63 |
33 |
43 |
31 |
25 |
16 |
15 |
14 |
32 |
21 |
| Moxifloxacin |
5 |
2 |
14 |
3 |
64 |
43 |
22 |
18 |
43 |
27 |
4 |
8 |
13 |
15 |
17 |
12 |
| Gatifloxacin |
30 |
1 |
14 |
4 |
36 |
25 |
7 |
6 |
23 |
17 |
6 |
6 |
15 |
14 |
13 |
7 |
| Gentamicin |
87 |
31 |
36 |
21 |
43 |
38 |
30 |
24 |
37 |
29 |
27 |
16 |
35 |
21 |
25 |
16 |
| Mean Resistance |
77 |
28 |
30 |
15 |
42 |
34 |
54 |
39 |
26 |
18 |
23 |
20 |
35 |
28 |
||
Zhang et al. Globalization and Health 2006 2:6 doi:10.1186/1744-8603-2-6 |
||||||||||||||||